Chapter title |
AAV6 Vector Production and Purification for Muscle Gene Therapy
|
---|---|
Chapter number | 18 |
Book title |
Duchenne Muscular Dystrophy
|
Published in |
Methods in molecular biology, January 2018
|
DOI | 10.1007/978-1-4939-7374-3_18 |
Pubmed ID | |
Book ISBNs |
978-1-4939-7373-6, 978-1-4939-7374-3
|
Authors |
Christine L. Halbert, James M. Allen, Jeffrey S. Chamberlain |
Abstract |
Vectors derived from adeno-associated viruses (AAV) have been generated using numerous naturally occurring and synthetic serotypes of the virus. Such vectors have proven to be extremely useful for a variety of gene transfer studies, both in vitro and in vivo, and are increasingly being used in gene therapy protocols for a variety of human disorders. Methods to produce AAV vectors typically rely on co-transfection of several different plasmid vectors that carry the transgene of interest (the gene to be delivered , in a "transfer plasmid") and helper genes needed for AAV vector replication and packaging (helper plasmids). While the methods used to generate AAV are conceptually simple, minor variations in a variety of steps can result in significant differences in the overall yield of vector. Here we describe protocols for generating vectors derived from AAV6, which are particularly useful for gene transfer to muscle tissues. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 21 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 19% |
Researcher | 4 | 19% |
Student > Master | 2 | 10% |
Student > Ph. D. Student | 1 | 5% |
Professor > Associate Professor | 1 | 5% |
Other | 0 | 0% |
Unknown | 9 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 6 | 29% |
Agricultural and Biological Sciences | 3 | 14% |
Neuroscience | 2 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Environmental Science | 1 | 5% |
Other | 1 | 5% |
Unknown | 7 | 33% |